Molecular and physicochemical aspects of the interactions of the tuberculostatics ofloxacin and rifampicin with liposomal bilayers: a 31P-NMR and DSC study

[1]  R. Pignatello,et al.  Interaction of monoamine oxidase inhibitors with dipalmitoyl phosphatidylcholine liposomes. A comparison between structure and calorimetric data , 1997 .

[2]  K. Joshi,et al.  Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice , 1997, Antimicrobial agents and chemotherapy.

[3]  P. Deol,et al.  Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. , 1997, Biochimica et biophysica acta.

[4]  F. Castelli,et al.  Indomethacin-Dipalmitoylphosphatidylcholine Interaction. A Calorimetric Study of Drug Release from Poly(Lactide-co-glycolide) Microspheres into Multilamellar Vesicles. , 1997, Drug delivery.

[5]  P. Tulkens,et al.  Interaction of the macrolide azithromycin with phospholipids. II. Biophysical and computer-aided conformational studies. , 1996, European journal of pharmacology.

[6]  R. C.-Gaudreault,et al.  Interaction of 4-tert-butyl-[3-(2-chloroethyl) ureido] benzene with phosphatidylcholine bilayers: a differential scanning calorimetry and infrared spectroscopy study. , 1996, Archives of biochemistry and biophysics.

[7]  E. Moase,et al.  Therapeutic opportunities for targeted liposomal drug delivery , 1996 .

[8]  S. Schreier,et al.  Molecular and physicochemical aspects of local anesthetic-membrane interaction. , 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[9]  L. Lim,et al.  A Differential Scanning Calorimetry Study of the Interaction of the Antimalarial Agent Halofanthrine with Dipalmitoyl Phosphatidyl Choline Bilayers. , 1995 .

[10]  Y. Oh,et al.  Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection , 1995, Antimicrobial agents and chemotherapy.

[11]  M. N. Jones.  The surface properties of phospholipid liposome systems and their characterisation. , 1995, Advances in colloid and interface science.

[12]  M. Mora,et al.  Role of headgroup structure in the phase behaviour of N-acylethanolamine phospholipids: hydrogen-bonding ability and headgroup size. , 1994, Chemistry and physics of lipids.

[13]  H. P. Gupta,et al.  Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice , 1994, Antimicrobial Agents and Chemotherapy.

[14]  R. Epand,et al.  Analogues of tetramethylpyrazine affect membrane fluidity of liposomes: relationship to their biological activities. , 1994, European journal of pharmacology.

[15]  G. Betageri,et al.  Liposome Drug Delivery Systems , 1993 .

[16]  G. Gregoriadis.  Liposomes, a tale of drug targeting. , 1993, Journal of drug targeting.

[17]  L. Packer,et al.  Progress in Membrane Biotechnology , 1991, ALS Advances in Life Sciences.

[18]  A. Verkleij,et al.  The dissimilar interactions of the calcium antagonist flunarizine with different phospholipid classes and molecular species: a differential scanning calorimetry study. , 1990, Biochimica et biophysica acta.

[19]  R. Lewis,et al.  Studies on the purified Na+,Mg(2+)-ATPase from Acholeplasma laidlawii B membranes: a differential scanning calorimetric study of the protein-phospholipid interactions. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.